Latest News

AlphaVax Progresses a Prophylactic HSV Vaccine

ViiV Healthcare launches: A new specialist HIV company dedicated to delivering advances in HIV treatment and care

PRIMA BIOMED SECURES JAPANESE PATENT FOR CANCER VAC

Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris

Two new appointments to BioAlliance Pharma's Supervisory Board in phase with the company's development

Argos Therapeutics Presents Positive Phase 2 Viral Load and Immune Response Data for Arcelis(TM) HIV Program at the AIDS Vaccine 2009 Conference

Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data at the IDF's 20TH World Diabetes Congress

Sernova's Cell Pouch System(tm) and Sertolin(tm) Preclinical Efficacy Presented at Leading International Islet Transplant Conference

TcLand Expression Launches An International, Multicenter Clinical Validation Study

BioAlliance Pharma announces Phase I trial for Fentanyl Lauriad

More news... | RSS Feed...

Most Viewed

CombinatoRx-Derived Combination Drug Candidate, Prednisporin, Acquired by Sanofi-Aventis Through Proposed Acquisition of Fovea Pharmaceuticals

Plexxikon Treats Initial Patient With First-in-Class Drug in Phase 1 Trial

Crucell HIV Vaccine: Promising Preliminary Results Phase I Study Presented by Dr Dan Barouch at AIDS Vaccine 2009 in Paris

Inovio Biomedical Therapeutic Cervical Cancer Vaccine Demonstrates Safety and Immunogenicity in Clinical Trial

Panenza

FDA Approves Berinert to Treat Abdominal Attacks, Facial Swelling Associated With Hereditary Angioedema

Sequella Obtains Funding to Continue Expansion of its Anti-infectives Pipeline

Sequella Receives American Recovery and Reinvestment Funding through the NIH

TcLand Expression Launches An International, Multicenter Clinical Validation Study

Two new appointments to BioAlliance Pharma's Supervisory Board in phase with the company's development

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire